- Joined
- Aug 3, 2002
- Messages
- 252
- Reaction score
- 4
what i got in my e-mail recently - 
Ralph L. Sacco, M.D., M.S., professor of neurology and epidemiology at Columbia University and an internationally renowned expert on stroke, has been named chairman of the Department of Neurology at the University of Miami Leonard M. Miller School of Medicine.
In 1990 Dr. Sacco established the pioneering Northern Manhattan Stroke Study, funded by the National Institutes of Health. The community-based research showed that Hispanics have a greater incidence of certain types of stroke, while exercise and moderate alcohol use were found to offer some protection against stroke risk. The research has since been expanded to include a genetic study of high-risk Caribbean Hispanic families.
Dr. Sacco, who is also associate chair of neurology for clinical research and training at Columbia and director of the Stroke and Critical Care Division at New York Presbyterian Hospital, received his medical degree from Boston University School of Medicine and a masters degree in epidemiology from the Columbia University School of Public Health. He did his residency in neurology at Presbyterian Hospital, and completed his postdoctoral training in stroke and epidemiology at Columbia under a neuroepidemiology training grant funded by the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health.
The University of Miami has always had a long and strong tradition as an excellent neurology department, and I am looking forward to working with the incredible team already assembled and helping to make things even better, said Dr. Sacco. I really have three main goals for the department: to be the best provider of neurological clinical care for South Florida and beyond; to expand research, both the basic science research that is already well developed, and new areas of clinical translational research; and to provide excellence in education for the neurological practitioners of tomorrow.
Dr. Sacco is also the principal investigator of the New York Columbia Collaborative Specialized Program in Translational Research in Acute Stroke. One of only seven NIH programs of its kind, the overall goal is to enhance the delivery of acute stroke patient care with a focus on a high-risk disadvantaged population. The program includes three translational projects designed to get advances in stroke clinical care to the patient faster.
In addition, Dr. Sacco is on the editorial board of the journals Stroke, Neuroepidemiology, and Nature Clinical Practice Neurology, and has more than 475 original articles, case reports, book chapters and abstracts to his credit. He was the lead author on the most recent guidelines from the American Heart Association on how to prevent a second stroke in patients who have already had a stroke or a transient ischemic attack (TIA). Sacco is also the co-chair of the worlds largest secondary stroke prevention trial and has been involved in numerous stroke clinical trials.
We are extremely excited not only for our institution, but for everyone who lives in South Florida, to have someone of Dr. Saccos caliber leading one of the finest departments of neurology in the country, said Pascal Goldschmidt, M.D., senior vice president for medical affairs and dean of the Miller School of Medicine. Stroke is the third leading cause of death in this country, and to have a recognized world expert on this devastating condition at our School of Medicine will boost the opportunity for our great stroke doctors and scientists and could have an impact on everyone who lives here.
Dr. Sacco, 49, is a fellow of the Stroke and Epidemiology Councils of the American Heart Association, a fellow of the American Academy of Neurology, and a member of the American Neurological Association. He is currently a member of the board of directors for both the American Heart Association and the American Academy of Neurology. Last year he received the prestigious William Feinberg Award for Excellence in Clinical Stroke from the American Heart Association.
Florida has one of the fastest growing aging populations in the country, Dr. Sacco said. We need to be well poised to provide outstanding medical care for the neurological conditions common in an aging population such as stroke, Alzheimers, and Parkinsons disease.
Ralph L. Sacco, M.D., M.S., professor of neurology and epidemiology at Columbia University and an internationally renowned expert on stroke, has been named chairman of the Department of Neurology at the University of Miami Leonard M. Miller School of Medicine.
In 1990 Dr. Sacco established the pioneering Northern Manhattan Stroke Study, funded by the National Institutes of Health. The community-based research showed that Hispanics have a greater incidence of certain types of stroke, while exercise and moderate alcohol use were found to offer some protection against stroke risk. The research has since been expanded to include a genetic study of high-risk Caribbean Hispanic families.
Dr. Sacco, who is also associate chair of neurology for clinical research and training at Columbia and director of the Stroke and Critical Care Division at New York Presbyterian Hospital, received his medical degree from Boston University School of Medicine and a masters degree in epidemiology from the Columbia University School of Public Health. He did his residency in neurology at Presbyterian Hospital, and completed his postdoctoral training in stroke and epidemiology at Columbia under a neuroepidemiology training grant funded by the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health.
The University of Miami has always had a long and strong tradition as an excellent neurology department, and I am looking forward to working with the incredible team already assembled and helping to make things even better, said Dr. Sacco. I really have three main goals for the department: to be the best provider of neurological clinical care for South Florida and beyond; to expand research, both the basic science research that is already well developed, and new areas of clinical translational research; and to provide excellence in education for the neurological practitioners of tomorrow.
Dr. Sacco is also the principal investigator of the New York Columbia Collaborative Specialized Program in Translational Research in Acute Stroke. One of only seven NIH programs of its kind, the overall goal is to enhance the delivery of acute stroke patient care with a focus on a high-risk disadvantaged population. The program includes three translational projects designed to get advances in stroke clinical care to the patient faster.
In addition, Dr. Sacco is on the editorial board of the journals Stroke, Neuroepidemiology, and Nature Clinical Practice Neurology, and has more than 475 original articles, case reports, book chapters and abstracts to his credit. He was the lead author on the most recent guidelines from the American Heart Association on how to prevent a second stroke in patients who have already had a stroke or a transient ischemic attack (TIA). Sacco is also the co-chair of the worlds largest secondary stroke prevention trial and has been involved in numerous stroke clinical trials.
We are extremely excited not only for our institution, but for everyone who lives in South Florida, to have someone of Dr. Saccos caliber leading one of the finest departments of neurology in the country, said Pascal Goldschmidt, M.D., senior vice president for medical affairs and dean of the Miller School of Medicine. Stroke is the third leading cause of death in this country, and to have a recognized world expert on this devastating condition at our School of Medicine will boost the opportunity for our great stroke doctors and scientists and could have an impact on everyone who lives here.
Dr. Sacco, 49, is a fellow of the Stroke and Epidemiology Councils of the American Heart Association, a fellow of the American Academy of Neurology, and a member of the American Neurological Association. He is currently a member of the board of directors for both the American Heart Association and the American Academy of Neurology. Last year he received the prestigious William Feinberg Award for Excellence in Clinical Stroke from the American Heart Association.
Florida has one of the fastest growing aging populations in the country, Dr. Sacco said. We need to be well poised to provide outstanding medical care for the neurological conditions common in an aging population such as stroke, Alzheimers, and Parkinsons disease.
